The role of selected cytochrome P450 enzymes on the bioactivation of aflatoxin B1 by duck liver microsomes

Avian Pathology

Volumn 39, Issue 4, 2010, Pages 279-285

  Diaz, Gonzalo J ^a   Murcia, Hansen W ^a   Cepeda, Sandra M ^a   Boermans, Herman J ^b  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; AFLATOXIN B1 2,3 OXIDE; AFLATOXIN B1-2,3-OXIDE; CYTOCHROME P450; DRUG DERIVATIVE;

ANIMAL; ARTICLE; DUCK; FEMALE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER MICROSOME; MALE; METABOLISM; WESTERN BLOTTING;

AFLATOXIN B1; ANIMALS; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 ENZYME SYSTEM; DUCKS; FEMALE; FLUORESCENCE; MALE; MICROSOMES, LIVER;

ANAS; ANAS PLATYRHYNCHOS;

EID: 77955581760     PISSN: 03079457     EISSN: 14653338     Source Type: Journal    
DOI: 10.1080/03079457.2010.495109     Document Type: Article

References (38)

1. Barraud, L., Guerret, S., Chevallier, M., Borel, C., Jamard, C., Trepo, C., et al. (1999). Enhanced duck hepatitis B virus gene expression following aflatoxin B1 exposure. Hepatology, 29, 1317-1323.
2. Bisswanger, H. (2008). Enzyme Kinetics. Principles and Methods 2nd edn. Weinheim: Wiley-VCH Verlag GmbH & Co.
3. Blanchard, J. (1981). Evaluation of the relative efficacy of various techniques for deproteinizing plasma samples prior to high-performance liquid chromatography analysis. Journal of Chromatography, 226,455-460.
4. Bunger, J., Westphal, G., Monnich, A., Hinnendahl, B., Hallier, E. & Muller, M. (2004). Cytotoxicity of occupationally and environmen- tally relevant mycotoxins. Toxicology, 202, 199-211.
5. Diaz, G.J., Cortés, A. & Botero, L. (2009). Evaluation of the ability of a feed additive to ameliorate the adverse effects of aflatoxins in turkey poults. British Poultry Science, 50, 240-250.
6. Do, J.H. & Choi, D. (2007). Aflatoxins: detection, toxicity, and biosynthesis. Biotechnology and Bioprocess Engineering, 12, 585-593.
7. Doi, A.M., Patterson, P.E. & Gallagher, E.P. (2002). Variability in aflatoxin B1 macromolecular binding and relationship to biotransformation enzyme expression in human prenatal and adult liver. Toxicology and Applied Pharmacology, 181, 48-59.
8. Eagling, V.A., Tjia, J.F. & Back, D.J. (1998). Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes. British Journal of Clinical Pharmacology, 45, 107-114.
9. Eaton, D.L. & Gallagher, E.P. (1994). Mechanisms of aflatoxin carcinogenesis. Annual Review of Pharmacology and Toxicology, 34, 135-172.
10. Fink, D.W. & Koehler, W.R. (1970). pH effects on fluorescence of umbelliferone. Analytical Chemistry, 42, 990-993.
11. Gallagher, E., Kunze, K.L., Stapleton, P.L. & Eaton, D.L. (1996). The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450-1A2 and 3A4. Toxicology and Applied Pharmacology, 141, 595-606.
12. Granvil, C.P., Krausz, K.W., Gelboin, H.V., Idle, J.R. & Gonzales, F.J. (2002). 4-Hydroxylation of debrisoquine by human CYP1A1 and its inhibition by quinidine and quinine. Journal of Pharmacology and Experimental Therapeutics, 301, 1025-1032.
13. Guengerich, F.P., Johnson, W.W., Shimada, T., Ueng, Y., Yamazaki, H. & Langouët, S. (1998). Activation and detoxication of aflatoxin B1. Mutation Research, 402, 121-128.
14. Guengerich, F.P., Johnson, W.W., Ueng, Y., Yamazaki, H. & Shimada, T. (1996). Involvement of cytochrome P450, glutathione S-transferase and epoxide hydrolase in the metabolism of aflatoxin B1 and relevance to risk of human liver cancer. Enviromental Health Perspectives, 104, 557-562.
15. Halpert, J.R., Guengerich, F.P., Bend, J.R. & Correia, M.A. (1994). Selective inhibitors of cytochromes P450. Toxicology and Applied Pharmacology, 125, 163-175.
16. Kadian, S.K., Monga, D.P. & Goel, M.C. (1988). Effect of aflatoxin B1 on the delayed hypersensitivity and phagocytic activity of reticuloen- dotelial system in chickens. Mycopathologia, 104, 33-36.
17. Kakkar, T., Boxenbaum, H. & Mayersohn, M. (1999). Estimation of Ki in a competitive enzyme-inhibition model: comparisons among three methods of data analysis. Drug Metabolism and Disposition, 27, 756-762.
18. Kennedy, S.W., Lorenzen, A., Jones, S.P., Hahn, M.E. & Stegeman, J.J. (1996). Cytochrome P4501A induction in avian hepatocyte cultures: a promising approach for predicting the sensitivity of avian species to toxic effects of halogenated aromatic hydrocarbons. Toxicology and Applied Pharmacology, 141, 214-230.
19. Klaassen, C.D. (Ed.). (2008). Casarett and Doull's Toxicology: The Basic Science of Poisons 7th edn. New York: McGraw Hill Medical.
20. Klein, P., Buckner, R., Kelly, J. & Coulombe, R. (2000). Biochemical basis for the extreme sensitivity of turkeys to aflatoxin B1. Toxicology and Applied Pharmacology, 165, 45-52.
21. Kunze, K.L. & Trager, W.F. (1993). Isoform-selective mechanism-based inhibition of human cytochrome P450-1A2 by furafylline. Chemical Research in Toxicology, 6, 649-656.
22. Laemmli, U. (1970). Cleavage or structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
23. Leclercq, I., Desager, J.P., Vandenplas, C. & Horsmans, Y. (1996). Fast determination of low level cytochrome P-450-1A1 activity by high- performance liquid chromatography with fluorescence or visible absorbance detection. Journal of Chromatography B, 681, 227-232.
24. Leeson, S., Diaz, G.J. & Summers, J.D. (1995). Poultry Metabolic Disorders and Mycotoxins (pp. 249-280). Guelph, ON: University Books.
25. Lozano, M.C. & Diaz, G.J. (2006). Microsomal and cytosolic biotransformation of aflatoxin B1 in four poultry species. British Poultry Science, 47, 734-741.
26. Marangoni, A.G. (2003). Enzyme Kinetics:A Modern Approach. Hoboken: John Wiley & Sons.
27. McLean, M. & Dutton, M.F. (1995). Cellular interactions and metabolism of aflatoxin: an update. Pharmacology and Therapeutics, 65, 163-192.
28. Oliveira, C.A.F., Rosmaninho, J.F., Butkeraitis, P., Corrêa, B., Reis, T.A., Guerra, J.L., et al. (2002). Effect of low levels of dietary aflatoxin B1 on laying japanese quail. Poultry Science, 81, 976-980.
29. Omiecinski, C.J., Remmel, R.P. & Hosagrahara, V.P. (1999). Concise review of the cytochrome P450s and their role in toxicology. Toxicological Sciences, 48, 151-156.
30. Pereira, V.A., Auler Jr, J.O., Carmona, M.J., Mateus, F.H., Lanchote, V.L., Breimer, D.D. & Santos, S.R.C.J. (2000). A micromethod for quantitation of debrisoquine and 4-hydroxydebrisoquine in urine by liquid chromatography. Brazilian Journal of Medical and Biological Research, 33, 509-514.
31. Raynal, M., Bailly, J.D., Bernard, G. & Guerre, P. (2001). Effects of fumonisin B1 present in Fusarium moniliforme culture material on drug metabolizing enzyme activities in ducks. Toxicology Letters, 121, 179-190.
32. Redinbaugh, M.G. & Turley, R.B. (1986). Adaptation of the bicinchoninic acid protein assay for the use with microtiter plates and sucrose gradient fractions. Analytical Biochemistry, 153, 267-271.
33. Riviere, J.L. (1992). Hepatic microsomal monooxygenase activities in natural populations of the Mallard Duck Anas platyrhynchos, the Tufted Duck Aythya fuligula and the Great Crested Grebe Podiceps cristatus. Ecotoxicology, 1, 117-135.
34. SAS Institute Inc. (2008). SAS/STAT® 9.2 User's Guide. Cary, NV: SAS Institute, Inc.
35. Sesardic, D., Boobis, A.R., Murray, B.P., Murray, S., Segura, J., De La Torre, R. & Davies, D.S. (1990). Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man. British Journal of Clinical Pharmacology, 29, 651-663.
36. Shim, S.C., Pae, A.N. & Lee, Y.J. (1988). Mechanistic studies on the photochemical degradation of nifedipine. Bulletin of the Korean Chemical Society, 9, 271-332.
37. Verma, R.J. (2004). Aflatoxin causes DNA damage. International Journal of Human Genetics, 4, 231-236.
38. Wild, C.P. & Turner, P.C. (2002). The toxicology of aflatoxins as a basis for public health decisions. Mutagenesis, 17, 471-481.